TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Share-based Compensation (2020)

TFA Therapeutics (RAJAF) posted Share-based Compensation of $19371.0 for Q4 2020.

Analysis

TFA Therapeutics (RAJAF) Share-based Compensation (2020) Analysis & Trends

TFA Therapeutics has reported Share-based Compensation for 1 years, with the latest figure at $19371.0 in Q4 2020.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Colgate Palmolive 70.76 Bn 69.72 Bn 3.30 Bn 38.00 Mn
2 Kenvue 35.95 Bn 34.84 Bn 2.30 Bn 56.00 Mn
3 Kimberly Clark 34.91 Bn 34.08 Bn 1.60 Bn 41.00 Mn
4 Bath & Body Works 3.94 Bn 3.15 Bn 692.00 Mn -
5 Prestige Consumer Healthcare 2.94 Bn 2.87 Bn - -
6 Perrigo 2.07 Bn 1.67 Bn 313.90 Mn 6.80 Mn
7 Edgewell Personal Care 1.33 Bn 933.73 Mn 242.50 Mn 5.70 Mn
8 Herbalife 1.30 Bn 935.57 Mn 1.03 Bn 29.40 Mn
9 TFA Therapeutics 1.02 Bn 1.02 Bn - -
10 Honest Company 682.25 Mn 576.35 Mn 40.36 Mn 3.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 19,371.00